Raymond Siatkowski to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications Raymond Siatkowski has written about Receptors, Vascular Endothelial Growth Factor.
Connection Strength
0.045
-
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. JAMA Ophthalmol. 2020 06 01; 138(6):698-701.
Score: 0.045